Guide to health industries at risk in debt deal
July 1, 2011
by Matt DoBias
Drugmakers. During the reform debate, the Democrats definitely didn’t want the drug lobby blasting away with attack ads. And they took care of the problem. PhRMA pitched in $80 billion in savings over 10 years — providing some of the money the law uses to close the “doughnut hole” in Medicare prescription drug coverage.
In return, though, the White House had to agree to resist any effort to let Medicare use its bulk purchasing power to negotiate lower prescription drug prices. Democrats in Congress resisted that part of the deal, but the idea stayed out of the law. Now, however, Democrats want to bring it back as part of the debt ceiling negotiations.
View the full story (some sites require registration)